As of 2025-01-17, the Relative Valuation of Tonix Pharmaceuticals Holding Corp (TNXP) is (15.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.24 USD, the upside of Tonix Pharmaceuticals Holding Corp based on Relative Valuation is -6836.5%.
The range of the Relative Valuation is (14.44) - (13.37) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.0x - 30.6x | 25.3x |
| Forward P/E multiples | 18.4x - 18.5x | 18.4x |
| Fair Price | (14.44) - (13.37) | (15.83) |
| Upside | -6246.7% - -5791.0% | -6836.5% |
| Date | P/E |
| 2025-01-13 | -0.34 |
| 2025-01-10 | -0.39 |
| 2025-01-08 | -0.35 |
| 2025-01-07 | -0.40 |
| 2025-01-06 | -0.43 |
| 2025-01-03 | -0.43 |
| 2025-01-02 | -0.43 |
| 2024-12-31 | -0.46 |
| 2024-12-30 | -0.50 |
| 2024-12-27 | -0.47 |
| 2024-12-26 | -0.51 |
| 2024-12-24 | -0.53 |
| 2024-12-23 | -0.56 |
| 2024-12-20 | -0.85 |
| 2024-12-19 | -0.79 |
| 2024-12-18 | -0.50 |
| 2024-12-17 | -0.46 |
| 2024-12-16 | -0.73 |
| 2024-12-13 | -0.33 |
| 2024-12-12 | -0.32 |
| 2024-12-11 | -0.28 |
| 2024-12-10 | -0.27 |
| 2024-12-09 | -0.26 |
| 2024-12-06 | -0.25 |
| 2024-12-05 | -0.24 |
| 2024-12-04 | -0.24 |
| 2024-12-03 | -0.26 |
| 2024-12-02 | -0.26 |
| 2024-11-29 | -0.26 |
| 2024-11-27 | -0.26 |
| 2024-11-26 | -0.26 |
| 2024-11-25 | -0.27 |
| 2024-11-22 | -0.26 |
| 2024-11-21 | -0.28 |
| 2024-11-20 | -0.26 |
| 2024-11-19 | -0.22 |
| 2024-11-18 | -0.18 |
| 2024-11-15 | -0.18 |
| 2024-11-14 | -0.19 |
| 2024-11-13 | -0.20 |
| 2024-11-12 | -0.20 |
| 2024-11-11 | -0.19 |
| 2024-11-08 | -0.19 |
| 2024-11-07 | -0.20 |
| 2024-11-06 | -0.19 |
| 2024-11-05 | -0.20 |
| 2024-11-04 | -0.20 |
| 2024-11-01 | -0.19 |
| 2024-10-31 | -0.20 |
| 2024-10-30 | -0.21 |